Home » Drug Information » FDA Approved Drugs » 1996
The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.
Company:
Sandoz Pharmaceuticals
Approval Status:
Approved November 1996
Specific Treatments:
cold symptoms, including sneezing and runny nose
Therapeutic Areas
Pulmonary/Respiratory DiseasesFamily MedicineInfections and Infectious Diseases
Common Cold
Tavist-D has been approved for the treatment of cold symptoms, including sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others.
Copyright © 1995-2018 CenterWatch.
Clinical Trial Portals Absolutely, Positively Essential for Small, Mid-Size Biotech Firms A WCG | CenterWatch FREE Webinar Friday, April 27, 2018 • 1:30 p.m. - 2:30 p.m. EDT
A WCG | CenterWatch FREE Webinar
Friday, April 27, 2018 • 1:30 p.m. - 2:30 p.m. EDT
REGISTER NOW